https://www.cureus.com/articles/102678-reduction-of-cardiovascular-risk-using-proprotein-convertase-subtilisinkexin-type-9-inhibitors-in-patients-with-acute-coronary-syndrome-a-systematic-review
0
0
2/5/23 at 6:31pm
Organization
Cureus.com
58 words
0
Comments
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a hepatic enzyme that regulates blood cholesterol levels by degrading low-density lipoprotein (LDL) receptors from the surface of hepatocytes. Studies have shown that inhibiting this molecule decreases …
You are the first to view
Create an account
or login to join the discussion